18 noviembre 2014
Induced pluripotent stem (iPS) cells from Werner Syndrome fibroblasts have been established, scientists report. The therapeutic methods for this disease are very limited. It is expected that patient-derived iPS cells can be used for the development of innovative therapies. Additionally, the mutated gene in patient-derived iPS cells can be corrected by genome editing. This advantage will be help in the development of new gene and cell therapies for Werner syndrome.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/YJZc0sEQwPY/141118105414.htm
